ResMed, F&P put patent disputes behind them

Wednesday, February 20, 2019

SAN DIEGO and AUCKLAND, N.Z. – ResMed and Fisher & Paykel Healthcare have agreed to settle all outstanding patent infringement disputes between the two companies. The settlement includes no payment or admission of liability by either side, according to a press release. Under the agreement, all ongoing proceedings against named products—including ResMed’s AirSense flow generators; AirFit P10, Swift LT and Swift FX masks; and F&P’s Simplus, Eson and Eson 2 masks—will be dismissed. “This agreement supports the best interests of ResMed and all of our stakeholders, including patients, providers, physicians, and shareholders,” said ResMed CEO Mick Farrell. F&P also said it was pleased with the outcome. “We have an ongoing commitment to improve patient care and outcomes through inspired and world-leading healthcare solutions and this resolution supports that commitment,” said CEO Lewis Gradon. The two companies have been embroiled in disputes for several years.